Denecimig, sold under the brand name Frehemgo, is a antihemorrhagic medication used for the treatment of hemophilia A. It is a fully human modified immunoglobulin G4 bispecific antibody that acts as a mimetic of activated factor VIII.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.